Oral Cancer Diagnostics Market Insights
According to Market Research Future, the global oral cancer diagnostics market is estimated to reach a CAGR of 6.94% to attain USD 7,367.90 Million during the forecast period, 2016-2024.
Early diagnosis of oral cancer is highly important as the treatment of the disease relies on various stages, and earlier the cancer is diagnosed high are the chances to eradicate the cancerous growth with easy, effective methods. Oral cancer majorly detected in various conditions such as cheeks, lips, tongue, sinuses, the floor of the mouth, and pharynx.
A rise in the population suffering from oral cancer, spreading awareness about risk factors that lead to cancer, and a high adoption rate of effective diagnostic treatment in sync with research is driving the growth of the global market.
However, the high cost of new imaging systems for healthcare organizations and lack of skilled professionals and is anticipated to restrain the growth of the global market.
Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/8086
Oral Cancer Diagnostics Market Segmentation
The global oral cancer diagnostics market is majorly bifurcated on the basis of indication, diagnosis type, and end-user.
The information by indication segment is diversified into mucoepidermoid carcinoma, oral squamous cell carcinoma, oral cavity lymphomas, oral verrucous carcinoma, and others.
Based on the diagnosis type, the global oral cancer diagnostics market is divided into Endoscopy, Biopsy, X-Ray, and Computed Tomography (CT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), Ultrasonography, Fluorescence Imaging, and others.
The global oral cancer diagnostics market is also classified into research and academic institutes, hospitals, clinics, and others, by end-user.
Oral Cancer Diagnostics Market Regional Outlook
The Americas are predicted to influence the global oral cancer diagnostics market and hold a maximum share during the forecast period. The growth of region is attributed to the well-established healthcare infrastructure, presence of major players, convenient reimbursement policies, and growing occurrence of oral cancer in Canada and the US.
The European market is predicted to witness considerable growth owing to increasing funding by government for research and development dedicated to high-tech treatment and devices, growing geriatric population that is more prone to get affected by diseases, cancer prevalence. According to the data presented by WHO, around 61,885 new oral cases and 24,063 deaths were reported due to oral cancer only in Europe, in 2018.
Asia Pacific region is anticipated to be a rapid-growing region in the global oral cancer diagnostics market owing to presence of massive patient pool, advancement in medical technology, growing awareness about diverse cancer diagnostic modalities, and investment in healthcare sector led by government. In the Asia Pacific region, India held a noteworthy share of 34.34% in the oral cancer diagnostics market in 2018.
The Middle East & Africa market for oral cancer diagnostics is anticipated to flourish moderately owing to the growing adoption of medical diagnosis modalities and awareness about various methods for cancer diagnostics.
Oral Cancer Diagnostics Market Key Players
The key players of the global market are emphasizing on new market access and expansions. Some of these major players involved in the development-based venture include Hitachi Ltd, Canon Medical Systems Corporation, QIAGEN, Hitachi Ltd, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Koninklijke Philips NV, PeriRx, LLC, Vigilant Biosciences, Inc., and GE Healthcare.
Oral Cancer Diagnostics Market Recent Updates
The Tata Centre for Development (TCD) at UChicago declared its alliance with the Tata Memorial Centre (TMC), that are among the largest cancer centers across the globe. Strand Life Sciences and UChicago Medicine in association with the TCD, have created a saliva-based test that could be applied in patients to diagnose tumor DNA from mouth cancers. The main motive of this research project is to sense the existence of mutations through a non-invasive method in patients with oral cancer.
Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/oral-cancer-diagnostics-market-8086
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.